Cargando…
Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974748/ https://www.ncbi.nlm.nih.gov/pubmed/32010237 http://dx.doi.org/10.1177/1759720X19895490 |